Onconetix (ONCO) vs XORTX Therapeutics (XRTX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Onconetix is the larger company by market cap ($3.5 million vs $3.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | ONCO | XRTX |
|---|---|---|
| Share price | $0.6615 | $1.80 |
| Market cap | $3.47M | $3.27M |
| 1-day change | +10.77% | +3.15% |
| P/E ratio (TTM) | 0.00 | — |
| Forward P/E | — | 2.24 |
| EPS (TTM) | $310.39 | $-2.61 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $209.50 | $7.05 |
| 52-week low | $0.58 | $1.59 |
| Distance from 52-week high | -99.68% | -74.47% |
| Average volume | 2.23M | 225.78K |
| Shares outstanding | 5.24M | 1.82M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ONCO vs XRTX FAQ
Which is bigger, Onconetix or XORTX Therapeutics?
Onconetix (ONCO) is larger, with a market capitalization of $3.47M compared with $3.27M for XORTX Therapeutics (XRTX).
Are Onconetix and XORTX Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.